Search Results - "Bergdorf, Kensey"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    HDAC inhibitors induce LIFR expression and promote a dormancy phenotype in breast cancer by Clements, Miranda E., Holtslander, Lauren, Edwards, Courtney, Todd, Vera, Dooyema, Samuel D. R., Bullock, Kennady, Bergdorf, Kensey, Zahnow, Cynthia A., Connolly, Roisin M., Johnson, Rachelle W.

    Published in Oncogene (26-08-2021)
    “…Despite advances in breast cancer treatment, residual disease driven by dormant tumor cells continues to be a significant clinical problem. Leukemia inhibitory…”
    Get full text
    Journal Article
  2. 2

    Novel three-dimensional cultures provide insights into thyroid cancer behavior by Lee, Mason A, Bergdorf, Kensey N, Phifer, Courtney J, Jones, Caroline Y, Byon, Sonia Y, Sawyer, Leah M, Bauer, Joshua A, Weiss, Vivian L

    Published in Endocrine-related cancer (01-02-2020)
    “…Thyroid cancer has the fastest growing incidence of any cancer in the United States, as measured by the number of new cases per year. Despite advances in…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Obtaining patient-derived cancer organoid cultures via fine-needle aspiration by Phifer, Courtney J., Bergdorf, Kensey N., Bechard, Matthew E., Vilgelm, Anna, Baregamian, Naira, McDonald, Oliver G., Lee, Ethan, Weiss, Vivian L.

    Published in STAR protocols (19-03-2021)
    “…Patient-derived tumor organoid cultures are an essential and innovative methodology for translational research. However, current techniques to establish these…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Immunofluorescent staining of cancer spheroids and fine-needle aspiration-derived organoids by Bergdorf, Kensey N., Phifer, Courtney J., Bechard, Matthew E., Lee, Mason A., McDonald, Oliver G., Lee, Ethan, Weiss, Vivian L.

    Published in STAR protocols (18-06-2021)
    “…Our organoid generation technique has allowed for the development of downstream organoid applications. Here, we detail an accessible, straightforward protocol…”
    Get full text
    Journal Article
  8. 8

    High-throughput drug screening of fine-needle aspiration-derived cancer organoids by Bergdorf, Kensey, Phifer, Courtney, Bharti, Vijaya, Westover, David, Bauer, Joshua, Vilgelm, Anna, Lee, Ethan, Weiss, Vivian

    Published in STAR protocols (18-12-2020)
    “…Generation of fine-needle aspiration (FNA)-derived cancer organoids has allowed us to develop a number of downstream applications. In this protocol, we start…”
    Get full text
    Journal Article
  9. 9

    Papillary thyroid carcinoma behavior: clues in the tumor microenvironment by Bergdorf, Kensey, Ferguson, Donna C, Mehrad, Mitra, Ely, Kim, Stricker, Thomas, Weiss, Vivian L

    Published in Endocrine-related cancer (01-06-2019)
    “…The prevalence of thyroid carcinoma is increasing and represents the most common endocrine malignancy, with papillary thyroid carcinoma (PTC) being the most…”
    Get full text
    Journal Article
  10. 10

    Comparison of the immunomodulatory effects of 3,4-dichlorophenyl-propanamide (DCPA) and N-(3,4-dichlorophenyl)-N-methylpropanamide (N-MeDCPA) by Barnett, John B, Bergdorf, Kensey N, McCall, Jamie L.

    Published in The Journal of immunology (1950) (01-05-2017)
    “…Abstract Glioblastoma multiforme (GBM) are stage IV brain tumors for which there is no curative treatment. GBM depend on Orai1 calcium channel signaling for…”
    Get full text
    Journal Article
  11. 11

    Advancing Therapeutics for Anaplastic Thyroid Carcinoma by Bergdorf, Kensey Nicolle

    Published 01-01-2022
    “…Thyroid cancer incidence is rapidly increasing in the United States, with over 45,000 patients projected to be diagnosed in 2022. While the vast majority of…”
    Get full text
    Dissertation
  12. 12

    Utilizing Three-Dimensional Culture Methods to Improve High-Throughput Drug Screening in Anaplastic Thyroid Carcinoma by Bergdorf, Kensey, Bauer, Joshua A, Westover, David, Phifer, Courtney, Murphy, Barbara, Tyson, Darren R, Lee, Ethan, Weiss, Vivian L

    Published in Cancers (07-04-2022)
    “…Anaplastic thyroid carcinoma (ATC) is the most aggressive endocrine neoplasm, with a median survival of just four to six months post-diagnosis. Even with…”
    Get full text
    Journal Article
  13. 13